ScoreWhy is Chengdu Kanghua Biological Products Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 1.40% and Operating profit at -12.80% over the last 5 years
2
Positive results in Mar 26
- NET PROFIT(HY) At CNY 60.81 MM has Grown at 188.9%
- OPERATING CASH FLOW(Y) Highest at CNY 877.9 MM
- RAW MATERIAL COST(Y) Fallen by -8.7% (YoY)
3
With ROE of 6.39%, it has a fair valuation with a 1.68 Price to Book Value
- Over the past year, while the stock has generated a return of -24.59%, its profits have fallen by -28.8%
- At the current price, the company has a high dividend yield of 0.8
4
Below par performance in long term as well as near term
- Along with generating -24.59% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Chengdu Kanghua Biological Products Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Chengdu Kanghua Biological Products Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Chengdu Kanghua Biological Products Co., Ltd.
-27.82%
-0.27
45.30%
China Shanghai Composite
3.23%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
1.40%
EBIT Growth (5y)
-12.80%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.38
Tax Ratio
15.85%
Dividend Payout Ratio
29.55%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.90%
ROE (avg)
16.97%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
1.59
EV to EBIT
18.44
EV to EBITDA
14.56
EV to Capital Employed
1.83
EV to Sales
3.89
PEG Ratio
NA
Dividend Yield
0.80%
ROCE (Latest)
9.95%
ROE (Latest)
6.39%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend14What is working for the Company
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
INVENTORY TURNOVER RATIO(HY)
Highest at 1.14 times
NET SALES(Q)
Highest at CNY 365.9 MM
OPERATING PROFIT(Q)
Highest at CNY 144.92 MM
OPERATING PROFIT MARGIN(Q)
Highest at 39.61 %
PRE-TAX PROFIT(Q)
Highest at CNY 126.68 MM
NET PROFIT(Q)
Highest at CNY 111.45 MM
EPS(Q)
Highest at CNY 0.88
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Chengdu Kanghua Biological Products Co., Ltd.
Net Sales
Highest at CNY 365.9 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 144.92 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at 39.61 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CNY 126.68 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 111.45 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.88
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Inventory Turnover Ratio
Highest at 1.14 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Footer loading
